drugset / Trial / NCT01666704
Proof of Concept Study of BMS-823778 to Assess the Effects on Atherosclerosis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of the study is to assess the effect of BMS-823778 on reducing atherosclerotic plaque inflammation
Timeline
- Start
- 2014-04
- Primary completion
- 2015-10
- Completion
- 2016-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMS-823778 | Small molecule | 2 mg | Oral |
| Subject | BMS-823778 | Small molecule | 15 mg | Oral |